Panel discussion

Thermo Fisher Scientific

Date:April 24, 2023
Time:16:45 – 17:30

Panel title

Trends in Process Intensification for Biomanufacturing

Panel summary

Over the last decade, methods and equipment of process intensification have been developed for biopharmaceutical processes. In this panel led by Thermo Fisher Scientific, we will review the recent advances in process intensification development for biologics manufacturing with several process development experts. We will exchange on the successes and challenges encountered during the development and technology transfer of intensified processes through a Q & A session.

Speaker information


Dr. Arnaud Desponds, Sr. Manager, Business Management | Biologics, Thermo Fisher Scientific


Prof. Thomas Villiger, Professor of Bioprocess Technology, University of Applied Sciences and Arts Northwestern Switzerland FHNW, Institute of Pharma Technology
Preeti Phanse, BPS Upstream Labs SME | Biologics, Thermo Fisher Scientific
Dr. Edwige Dormond, Director, MSAT | Biologics, Thermo Fisher Scientific

Company profile

Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics, and commercial manufacturing to customers through our Patheon brand. With more than 60 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services, and commercial manufacturing, and packaging

Open Door Day at Thermo Fisher Scientific Biologics Lengnau – Linke activated on Monday

Follow us